Genishiro Konishi Md - 11356 College Point, NY

Business Name: Genishiro Konishi Md
Categorized In: Doctors
Address: 2231 College Point Boulevard, College Point, NY 11356
Phone Number: No number given
Contact Person: Genishiro Konishi
NAICS Code: 621111
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 1984
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Park Sang Ki - College Point, NY 11356
Vlacancich Tanya DDS - College Point, NY 11356
Jonnavithula Suhasini MD - College Point, NY 11356
Mattoo Nirmal K MD - College Point, NY 11356
Royzman Marina MD - College Point, NY 11356
Yang Shu R MD - College Point, NY 11356
Prasad Ankineedu N MD - College Point, NY 11356
Reddy Arpitha MD - College Point, NY 11356
Huded Dayanand V MD - College Point, NY 11356
Wang Shiush Dr - College Point, NY 11356
Mahankali Bhavani MD - College Point, NY 11356
Denneke Tsega MD - College Point, NY 11356
Matteo Richard J DC - College Point, NY 11356
Randolph Rosarion MD - College Point, NY 11356
Rosarion Randolph MD - College Point, NY 11356
Jong Kim Kuk - College Point, NY 11356
Ridgewood Dialysis Center - College Point, NY 11356
Malva Ruby R MD - College Point, NY 11356
Bruder Jack T MD - College Point, NY 11356
Desiraju Brinda MD - College Point, NY 11356

Genishiro Konishi Md provides professional Doctors from its single location at the coordinates 40.778753,-73.845922.

The company offers B2C variables under the SIC code 8011 and NAICS code 621111, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 1984, the company can now be visited at 2231 College Point Boulevard, College Point, New York 11356 or contacted through representative Genishiro Konishi at No number given.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Genishiro Konishi Md through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.